F171 PHARMACOLOGICAL EVALUATION OF A NEW CAPSAICIN MODEL WHICH INDUCES SECONDARY HYPERALGESIA, SECONDARY ALLODYNIA AND ONGOING PAIN IN HEALTHY VOLUNTEERS